EyePoint Pharmaceuticals, Inc. (EYPT) [Rocket]

Date Filed	Type	Description
02/25/2021	GN	EyePoint Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
02/04/2021	GN	EyePoint Pharmaceuticals Announces Closing of $115 Million Public Offering of Common Stock
02/01/2021	GN	EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock
01/28/2021	GN	EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of EYP-1901 for the Treatment of Wet AMD
01/11/2021	GN	EyePoint Pharmaceuticals Provides Business Update and Preliminary Fourth Quarter and Full-Year 2020 Net Product Revenues
01/03/2021	GN	EyePoint Pharmaceuticals Announces $15.7 Million Equity Investment by Asia Partner Ocumension Therapeutics
12/08/2020	GN	EyePoint Pharmaceuticals Announces 1-for-10 Reverse Stock Split
12/03/2020	GN	EyePoint Pharmaceuticals Reports Positive Results from GLP Toxicology Study of EYP-1901, a Potential Six-month Treatment of Wet Age-related Macular Degeneration
11/19/2020	GN	EyePoint Pharmaceuticals to Host Key Opinion Leader Virtual Roundtable on the Future of Drug Delivery for Wet AMD on December 4
11/10/2020	GN	EyePoint Pharmaceuticals Announces Presentations at the Upcoming American Academy of Ophthalmology 2020 Virtual Annual Meeting
10/08/2020	GN	EyePoint Pharmaceuticals Announces Amendment to CRG Debt Facility Modifying 2020 and 2021 Revenue Covenants
08/24/2020	GN	EyePoint Pharmaceuticals Secures New Purchase and Marketing Agreement with Vantage Outsourcing for DEXYCU®
08/20/2020	GN	EyePoint Pharmaceuticals Receives $9.5 Million in Upfront Cash from Ocumension Therapeutics Under Expanded License Agreements
07/29/2020	GN	EyePoint Pharmaceuticals Announces Second Quarter 2020 Financial Results Release Date and Conference Call Information
07/27/2020	GN	EyePoint Pharmaceuticals Presents Data Supporting YUTIQ?? at the American Society of Retina Specialists (ASRS) Virtual Annual Meeting
05/18/2020	GN	EyePoint Pharmaceuticals Presents Data Showcasing DEXYCU® at the American Society of Cataract and Refractive Surgery 2020 Virtual Annual Meeting
04/29/2020	GN	EyePoint Pharmaceuticals Announces First Quarter 2020 Financial Results Release Date and Conference Call Information
04/01/2020	GN	EyePoint Pharmaceuticals Provides COVID-19 Pandemic Business Operations Update
02/21/2020	GN	EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock